omega-n-methylarginine has been researched along with 6-ketoprostaglandin f1 alpha in 24 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 4,832 | 294 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (83.33) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busija, DW; Chen, J | 1 |
| Schröder, H; Schrör, K; Strobach, H | 1 |
| Ellis, EF; Nelson, GH; Nishimura, H; Rosenblum, WI | 1 |
| De Kimpe, SJ; Nijkamp, FP; Van Heuven-Nolsen, D | 1 |
| Di Rosa, M; Sautebin, L | 1 |
| Caputi, AP; Cook, JA; Halushka, PV; Zingarelli, B | 1 |
| Ikeda, U; Ishikawa, S; Kasahara, T; Okada, K; Saito, T; Shimada, K | 1 |
| MacDermot, J; McEwan, JR; Parsaee, H | 1 |
| Mundin, JW; Sumner, MJ; Watts, IS; White, DG | 1 |
| Evora, PR; Lin, PJ; Pearson, PJ; Schaff, HV | 1 |
| Goodman, LW; Rubin, LJ; Tod, ML; Tseng, CM | 1 |
| Busija, DW; Chen, J; Khreis, I | 1 |
| Antona, C; Biglioli, P; Buche, M; Guarino, A; Polvani, GL; Pompilio, G; Porqueddu, M; Rossoni, G; Sala, A | 1 |
| Agozzino, S; Bernareggi, M; Berti, F; Cereda, R; Giuliani, P; Mizrahi, J; Rossoni, G; Villa, L | 1 |
| Béa, ML; Berdeaux, A; Beverelli, F; Giudicelli, JF; Puybasset, L | 1 |
| Hamilton, LC; Warner, TD | 1 |
| Gimeno, M; González, E; Jawerbaum, A; Novaro, V; Sinner, D | 1 |
| Bernareggi, M; Berti, F; Boghen, M; De Gennaro Colonna, V; Locatelli, V; Müller, EE; Nilsson, M; Rossoni, G; Schweiger, F; Torsello, A | 1 |
| Fogh-Andersen, N; Hansen, JM; Johansen, NJ; Mollerup, HM; Strandgaard, S | 1 |
| Brown, NJ; Gainer, JV; Murphey, LJ; Vaughan, DE | 1 |
| Cao, H; Chen, Z; Kuang, Y; Wu, Z; Zhou, J | 1 |
| Bachschmid, M; Thurau, S; Ullrich, V; Zou, MH | 1 |
| Cao, H; Chen, XS; Wu, ZY | 1 |
| Beretta, G; Facino, RM; Rossoni, G; Santagati, NA | 1 |
3 trial(s) available for omega-n-methylarginine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Retention of endothelium-dependent properties in human mammary arteries after cryopreservation.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Analysis of Variance; Anti-Bacterial Agents; Arginine; Cryopreservation; Dose-Response Relationship, Drug; Endothelins; Endothelium, Vascular; Humans; In Vitro Techniques; Mammary Arteries; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1996 |
Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arachidonic Acid; Blood Pressure; Body Weight; Cardiovascular Physiological Phenomena; Cyclosporine; Dinoprostone; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Nitrates; Nitric Oxide; Nitrites; omega-N-Methylarginine; Reference Values; Renin; Sodium; Thromboxane B2 | 1999 |
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Adrenergic beta-Antagonists; Adult; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Forearm; Humans; Indomethacin; Infusions, Intra-Arterial; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Receptor, Bradykinin B2; Regional Blood Flow; Tissue Plasminogen Activator; Vasodilation; Vasodilator Agents | 2000 |
21 other study(ies) available for omega-n-methylarginine and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effects of trigeminal neurotransmitters on piglet pial arterioles.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Arterioles; Brain; Calcitonin Gene-Related Peptide; Dinoprostone; Indomethacin; Neurokinin A; Nitric Oxide; omega-N-Methylarginine; Pia Mater; Substance P; Swine; Trigeminal Nerve | 1992 |
Nitric oxide but not prostacyclin is an autocrine endothelial mediator.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Calcimycin; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; Dinoprostone; Endothelium, Vascular; Epoprostenol; Iloprost; Nitric Oxide; omega-N-Methylarginine; Second Messenger Systems; Swine | 1992 |
The endothelium-dependent effects of thimerosal on mouse pial arterioles in vivo: evidence for control of microvascular events by EDRF as well as prostaglandins.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Arterioles; Dinoprostone; Male; Mice; Nitric Oxide; omega-N-Methylarginine; Pia Mater; Thimerosal; Vasodilation | 1992 |
Bovine polymorphonuclear leukocytes increase sensitivity to noradrenaline in isolated mesenteric arteries.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arginine; Cattle; Free Radical Scavengers; In Vitro Techniques; Luminescent Measurements; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Neutrophils; Norepinephrine; omega-N-Methylarginine; Radioimmunoassay; Thromboxane B2 | 1992 |
Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats.
Topics: 6-Ketoprostaglandin F1 alpha; Amino Acid Oxidoreductases; Animals; Arginine; Dose-Response Relationship, Drug; Enzyme Induction; Epoprostenol; In Vitro Techniques; Injections, Subcutaneous; Lipopolysaccharides; Lung; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar | 1994 |
Increased nitric oxide synthesis during the development of endotoxin tolerance.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Arachidonic Acids; Arginine; Cells, Cultured; Drug Tolerance; Endotoxins; Lethal Dose 50; Lipopolysaccharides; Macrophages, Peritoneal; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Rats; Reference Values; Salmonella enteritidis | 1995 |
Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Arteriosclerosis; Cell Division; Cells, Cultured; Chemokine CCL2; Chemotactic Factors; Cyclic AMP; Cyclic GMP; DNA; Gene Expression; Humans; Indomethacin; Lipopolysaccharides; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Recombinant Proteins; Thymidine | 1995 |
Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Cattle; Cell Line; Endothelium, Vascular; Epoprostenol; Ionomycin; Nitric Oxide; omega-N-Methylarginine; Phosphotransferases; Signal Transduction; Staurosporine | 1993 |
The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arginine; Bradykinin; Carotid Arteries; Cattle; Cells, Cultured; Cyclic GMP; Endothelins; Endothelium, Vascular; Epoprostenol; Female; Hemoglobins; Histamine; Humans; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pregnancy; Swine; Umbilical Veins | 1993 |
Endothelium-dependent response of human internal mammary artery to hypoxia.
Topics: 6-Ketoprostaglandin F1 alpha; Arginine; Endothelium, Vascular; Humans; Hypoxia; Indomethacin; Mammary Arteries; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasodilation | 1993 |
NG-monomethyl-L-arginine paradoxically relaxes preconstricted canine intrapulmonary arteries.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arginine; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Endothelium, Vascular; Epoprostenol; Immunoenzyme Techniques; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Phenylephrine; Potassium Chloride; Pulmonary Artery; Serotonin; Vasodilation | 1993 |
Prostanoids promote pial arteriolar dilation and mask constriction to oxytocin in piglets.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Arginine; Arterioles; Blood Pressure; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Indomethacin; Microscopy; omega-N-Methylarginine; Oxytocin; Pia Mater; Radioimmunoassay; Swine; Vasoconstriction; Vasodilation | 1993 |
Protective effects of ITF 296 in the isolated rabbit heart subjected to global ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzoxazines; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrates; Nitric Oxide Synthase; omega-N-Methylarginine; Oxazines; Rabbits; Vasodilator Agents | 1995 |
Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Bradykinin; Coronary Vessels; Cyclooxygenase 1; Dogs; Enzyme Induction; Enzyme Inhibitors; Epoprostenol; In Vitro Techniques; Indans; Indomethacin; Isoenzymes; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Nitrobenzenes; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Up-Regulation | 1997 |
Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib.
Topics: 6-Ketoprostaglandin F1 alpha; Amidines; Analysis of Variance; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylamines; Celecoxib; Crotonates; Cyclooxygenase 2; Dexamethasone; Diclofenac; Enzyme Inhibitors; Hydroxybutyrates; Isoenzymes; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitriles; Nitrites; Nitrogen Dioxide; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Toluidines | 1998 |
Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Diabetes Mellitus, Type 2; Dinoprost; Dinoprostone; Enzyme Inhibitors; Female; Gestational Age; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Placenta; Pregnancy; Pregnancy in Diabetics; Prostaglandins; Rats; Rats, Wistar; Reference Values; Thromboxane B2 | 1998 |
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Animals; Aorta; Body Weight; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Homeostasis; Human Growth Hormone; Humans; Hypophysectomy; Male; Oligopeptides; omega-N-Methylarginine; Protective Agents; Rats; Rats, Sprague-Dawley; Vasodilation | 1999 |
Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carbon Tetrachloride Poisoning; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hypertension, Portal; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley | 1999 |
Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Cattle; Coronary Vasospasm; Coronary Vessels; Cytochrome P-450 Enzyme System; Endothelium, Vascular; In Vitro Techniques; Intramolecular Oxidoreductases; Lipopolysaccharides; Nitrates; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Polyethylene Glycols; Prostaglandin Endoperoxides; Receptors, Thromboxane; Superoxide Dismutase; Superoxides; Vasoconstriction; Vasodilation; Xanthine Oxidase | 2003 |
[The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hypertension, Portal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Random Allocation; Rats; Rats, Sprague-Dawley | 2003 |
Anti-ischemic activity and endothelium-dependent vasorelaxant effect of hydrolysable tannins from the leaves of Rhus coriaria (Sumac) in isolated rabbit heart and thoracic aorta.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Aorta, Thoracic; Biphenyl Compounds; Creatine Kinase; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythrocytes; Heart; Hydrolyzable Tannins; Indomethacin; L-Lactate Dehydrogenase; Male; Myocardial Reperfusion Injury; Norepinephrine; omega-N-Methylarginine; Oxadiazoles; Phytotherapy; Picrates; Plant Extracts; Plant Leaves; Prostaglandin-Endoperoxide Synthases; Rabbits; Rhus; Tumor Necrosis Factor-alpha; Vasoconstriction; Vasodilator Agents | 2009 |